✦ LIBER ✦

Mutations to increased antibiotic sensitivity in naturally-occurring gonococci

✍ Scribed by EISENSTEIN, BARRY I.; SPARLING, P. FREDERICK

Book ID: 109708305
Publisher: Nature Publishing Group
Year: 1978
Tongue: English
Weight: 448 KB
Volume: 271
Category: Article
ISSN: 0028-0836
DOI: 10.1038/271242a0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A gynogenetic screen to isolate naturall

A gynogenetic screen to isolate naturally occurring recessive mutations in Xenopus tropicalis

✍ Selina Noramly; Lyle Zimmerman; Amanda Cox; Renee Aloise; Marilyn Fisher; Robert 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 530 KB

Evidence suggesting a non-random charact

Evidence suggesting a non-random character to nucleotide replacements in naturally occurring mutations

✍ Fitch, Walter M. 📂 Article 📅 1967 🏛 Elsevier Science 🌐 English ⚖ 661 KB

Naturally Occurring Mutations in the PA

Naturally Occurring Mutations in the PA Gene Are Key Contributors to Increased Virulence of Pandemic H1N1/09 Influenza Virus in Mice

✍ Sun, Y.; Xu, Q.; Shen, Y.; Liu, L.; Wei, K.; Sun, H.; Pu, J.; Chang, K.-C.; Liu, 📂 Article 📅 2014 🏛 American Society for Microbiology 🌐 English ⚖ 935 KB

Naturally occurring resistance mutations

Naturally occurring resistance mutations to HIV-1 entry inhibitors in subtypes B, C, and CRF31_BC

✍ Leonardo Augusto Luvison Araújo; Dennis Maletich Junqueira; Rubia Marília de Med 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 258 KB

1207 NATURALLY OCCURRING RESISTANCE MUTA

1207 NATURALLY OCCURRING RESISTANCE MUTATIONS TO HCV DIRECT ACTING ANTIVIRAL AGENTS IN TREATMENT-NAÏVE PATIENTS IN CHINA

✍ Liu, Y.; Cai, Q.; Zhao, Z.; Gao, Z. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Naturally occurring dominant resistance

Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients

✍ Thomas Kuntzen; Joerg Timm; Andrew Berical; Niall Lennon; Aaron M. Berlin; Sarah 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

Resistance mutations to hepatitis C virus (HCV) nonstructural protein 3 (NS3) protease inhibitors in <1% of the viral quasispecies may still allow >1000-fold viral load reductions upon treatment, consistent with their reported reduced replicative fitness in vitro. Recently, however, an R155K proteas